Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Zeneca and Rutgers collaborate on apoptosis research

Dec. 4, 1996

Incyte-Affymetrix to develop and commercialize new chip-based genomic databases

Dec. 2, 1996

Expanded patent portfolio for Dyax technology

Dec. 2, 1996

Methods for screening for neurotoxicity offered for licensing

Dec. 2, 1996

3DP seeks partners for receptor-based drug discovery program

Nov. 29, 1996

Corporate partners sought for drug discovery collaboration based on 3DP technology

Nov. 29, 1996

Locus control region for transgenic expression available for licensing

Nov. 29, 1996

Discovery related to pharmacological screening and gene mapping available for licensing

Nov. 29, 1996

Univ. of Washington offers cell line for screening compounds

Nov. 29, 1996

Univ. of Washington offers human topo I-producing system for licensing

Nov. 29, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...